| Code | 0596E | ||||||||||
| MA number | 15/0092/22-S | ||||||||||
| Product Form: | plc ifc 1x500 mg (liek.skl.inj.) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Apta Medica Internacional d.o.o., Slovenia | ||||||||||
| Therapeutic Class: | 15 - ANTIBIOTICA (PROTI MIKROB. A VÍRUSOVÝM INFEKCIAM) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | glass vial |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 26.05.2022 |
| Validity: | 26.05.2027 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| Pediatric warnings: | Yes |
| PIL: |
PIL_Vancomycin AptaPharma 500 mg, 1000 mg plc ifc_04 2022.pdf
|
| SPC: |
SPC_Vancomycin AptaPharma 500 mg, 1000 mg plc ifc_04 2022.pdf
|
| Safety feature | Yes |
| Data update: | 08.06.2022 |
